Found 43 matching trials
Study of Efficacy of BZ019 in Large B-cell Lymphoma PHASE2 This is a single arm,open-label, non-randomized phase 2 study to determine ...
Show More Location
Shanghai Mengchao Cancer Hospital
Learn More & Join Trial
CAR-T Therapy Targeting CD19 and BCMA in Highly Sensitized Kidney Transplant Participants EARLY_PHASE1 The purpose of this study is to assess the safety, tolerability, and effica...
Show More Location
Tongji Hospital, Tongji Medical Collage of Huazhong University of Science & Technology
Learn More & Join Trial
A Phase 1/2 Study of CT120 in Patient With Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma PHASE1 This study is a single-armed, open-label,multicenter Phase 1/2 study to eva...
Show More Location
Multiple Locations
Learn More & Join Trial
Exploratory Study of Anti-BCMA-CD19 CAR-T Cell Therapy in Relapsed or Refractory IgG4-Related Disease PHASE2 The goal of this clinical trial is to test the safety and potential benefit...
Show More Location
Department of Rheumatology and Immunology, the First Medical Center, Chinese PLA General Hospital
Learn More & Join Trial
Universal CAR-T Cells (BRL-301) in Refractory Systemic Lupus Erythematosus NA This is an investigator initiated trial to assess the efficacy and safety o...
Show More Location
The First Affiliated Hospital, Zhejiang University School of Medicine
Learn More & Join Trial
A Clinical Study Exploring the Safety, Efficacy and Cell Metabolic Kinetics of Universal Car-t Cell Injection in CD19 and / or CD20 Positive Relapsed / Refractory B-cell Acute Lymphoblastic Leukemia in Adolescents, Children and Adults EARLY_PHASE1 This study is a single arm, open label, dose exploring clinical trial to ev...
Show More Location
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Learn More & Join Trial
Clinical Study of LV009 Injection for the Treatment of Relapsed/Refractory CD19-Positive Hematologic and Lymphoid Malignancies EARLY_PHASE1 Evaluate the safety, pharmacokinetic (PK) characteristics, and pharmacodyna...
Show More Location
PersonGen.Anke Cellular Therapeutice Co., Ltd.
Learn More & Join Trial
Universal CAR-T Cell Therapy for NHL NA This is a single-center, single-arm, open-label clinical study, and the sam...
Show More Location
Shanghi Tongji Hospital (Tongji Hospital of Tongji University)
Learn More & Join Trial
Senl_1904A and Senl_1904B Chimeric Antigen Receptor οΌCARοΌ T-Cell in the Treatment of r/ r Acute B Lymphocytic Leukemia PHASE1 This is an open, two arms, mask phase I clinical study to evaluate efficacy...
Show More Location
Hebei Yanda Ludaopei Hospital
Learn More & Join Trial
A Study of CC-97540, CD19-targeted NEX-T Chimeric Antigen Receptor (CAR) T Cells, in Subjects With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma PHASE1 This is a Phase 1, first-in-human, open-label, multicenter study of CC-9754...
Show More Location
Local Institution - 003
Learn More & Join Trial